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Abstract 
Background: Plasmodium falciparum erythrocyte membrane protein‑1 (PfEMP1) antigens play a critical role in host 
immune evasion. Serologic responses to these antigens have been associated with protection from clinical malaria, 
suggesting that antibodies to PfEMP1 antigens may contribute to natural immunity. The first N‑terminal constitutive 
domain in a PfEMP1 is the Duffy binding‑like alpha (DBL‑α) domain, which contains a 300 to 400 base pair region 
unique to each particular protein (the DBL‑α “tag”). This DBL‑α tag has been used as a marker of PfEMP1 diversity 
and serologic responses in malaria‑exposed populations. In this study, using sera from a malaria‑endemic region, 
responses to DBL‑α tags were compared to responses to the corresponding entire DBL‑α domain (or “parent” domain) 
coupled with the succeeding cysteine‑rich interdomain region (CIDR).
Methods: A protein microarray populated with DBL‑α tags, the parent DBL‑CIDR head structures, and downstream 
PfEMP1 protein fragments was probed with sera from Malian children (aged 1 to 6 years) and adults from the control 
arms of apical membrane antigen 1 (AMA1) vaccine clinical trials before and during a malaria transmission season. 
Serological responses to the DBL‑α tag and the DBL‑CIDR head structure were measured and compared in children 
and adults, and throughout the season.
Results: Malian serologic responses to a PfEMP1’s DBL‑α tag region did not correlate with seasonal malaria exposure, 
or with responses to the parent DBL‑CIDR head structure in either children or adults. Parent DBL‑CIDR head structures 
were better indicators of malaria exposure.
Conclusions: Larger PfEMP1 domains may be better indicators of malaria exposure than short, variable PfEMP1 frag‑
ments such as DBL‑α tags. PfEMP1 head structures that include conserved sequences appear particularly well suited 
for study as serologic predictors of malaria exposure.
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Background
Plasmodium falciparum erythrocyte membrane pro-
tein-1 (PfEMP1) antigens are critical to parasite seques-
tration, and their genetic diversity likely facilitates host 
immune system evasion. The var gene family encodes 
PfEMP1 antigens, whose extracellular binding region 
is made up of Duffy-binding-like (DBL) domains inter-
spersed with cysteine-rich interdomain regions (CIDRs). 
A 300–400 variable nucleotide region surrounded by 
semi-conserved motifs in the DBL-α domain, the first 
N-terminal var domain, acts as a unique “fingerprint” 
specific to individual vars. DBL-α “tag” sequencing facili-
tates analyses of both PfEMP1 genetic diversity [1, 2] and 
seroreactivity [3, 4].
Antibody responses to locally derived DBL-α tags in 
Papua New Guinea increased in magnitude and preva-
lence with age in children, suggesting that DBL-α tags 
correlate with malaria exposure and potentially the 
development of natural immunity to malaria [4]. In con-
trast, a subsequent study of seroreactivity to 3D7 strain 
PfEMP1 antigens found that sera from children with 
cerebral malaria or severe malarial anaemia did not dif-
fer in recognition of DBL-α tags compared to sera from 
matched uncomplicated malaria controls in Bandiagara, 
Mali, but did with respect to larger extracellular PfEMP1 
fragments [5].
To identify accurate markers of malaria exposure, 
serologic responses to the DBL-α tag of a PfEMP1 and 
its constitutive domains were measured. Serum samples 
from malaria-exposed Malian children, aged 1 to 6 years, 
and adults were studied on a custom PfEMP1 microar-
ray populated with DBL-α tags, parent DBL-CIDR head 
structures (i.e. the entire DBL-α domains encompass-
ing the tags with the succeeding CIDR domains), and 
downstream PfEMP1 fragments. The hypothesis was 
that seroreactivity to DBL-α tags among malaria-exposed 
individuals increases with age and with cumulative P. 
falciparum exposure. In addition, seroreactivity to the 
DBL-α tag was not predicted to correlate with seroreac-
tivity to the parent DBL-CIDR head structure, given the 
head structure’s additional structural components and its 
relative sequence conservation.
Methods
Protein microarray construction followed a four-step 
process that included: (1) PCR amplification of each 
complete or partial P. falciparum open reading frame, 
(2) in vivo recombination cloning, (3) in vitro transcrip-
tion/translation (IVTT), and (4) microarray chip printing 
[6]. This IVTT protein microarray platform has pro-
duced antibody responses strongly correlated with those 
from ELISA assays featuring purified proteins of several 
malaria vaccine candidate antigens [7]. The microarray 
included nine DBL-α tags that encode Group A, B, B/A, 
and C PfEMP1 antigens from the 3D7 reference genome; 
nine matched parent DBL-CIDR head structures; and 18 
matched downstream PfEMP1 fragments. Each DBL-α 
tag was expressed as a single protein fragment, and the 
corresponding DBL-CIDR head structure was expressed 
as a single protein fragment.
The protein microarrays were probed with sera from 18 
adults aged 18–55 years old in the control arm of a trial 
of an apical membrane antigen 1 (AMA1) vaccine adju-
vanted to GlaxoSmithKline’s AS02A (FMP2.1/AS02A) [8] 
and from 35 children aged 1 to 6 years in the control arm 
of a Phase II AMA1 vaccine (FMP2.1/AS02A) trial [9] 
using published methods [6]. These serum samples were 
collected with respect to two malaria transmission sea-
sons in rural Mali [adults: June 2005 (pre-malaria season) 
and December 2005 (post malaria season); children: May 
2007 (pre-malaria season) and September 2007 (peak-
malaria season)]. Sera from 11 US blood donors were 
used as negative controls. The data were background 
subtracted using the mean of the no-DNA controls, and 
negative fluorescence intensities were zeroed.
All participants or guardians of participants provided 
written informed consent, and the trial was conducted 
under the Declaration of Helsinki. The institutional 
review boards of the Faculty of Medicine, Pharmacy and 
Dentistry, Bamako, Mali, and the University of Maryland 
approved the study protocol.
Analysis
Seroprevalence
Seroprevalence is the proportion of serum samples that 
recognized a protein fragment. A serum sample rec-
ognized a protein fragment if the fluorescence inten-
sity was greater than two standard deviations above 
the malaria-naïve control mean for that fragment [10]. 
Group “recognition” of a protein fragment was defined 
as a pre-malaria transmission season mean fluorescence 
intensity for Malian children or adults that was greater 
than malaria-naïve controls, based on a two-sample Kol-
mogorov–Smirnov test as previously described [5, 11]. 
The McNemar’s test was used to determine if the propor-
tions of serorecognized DBL-α tags and corresponding 
DBL-CIDR head structures were significantly discordant.
Seroreactivity
Change in seroreactivity for a protein fragment between 
the pre- and peak season for children and pre- and post-
transmission season for adults was determined with a 
Wilcoxon signed-rank test for matched samples. Correla-
tion between seroreactivity of DBL-α tag and DBL-CIDR 
head structures was measured with the Spearman correla-
tion coefficient, rs. P-values were two-sided, and α = 0.05. 
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No adjustment was made for multiple comparisons as per 
previous protein microarray analyses [5, 7, 12].
Results
Fluorescence intensities to DBL-α tags and their parent 
DBL-CIDR head structures were measured using sera 
collected from Malian children and adults and North 
American malaria-naïve adult controls (Fig.  1). Overall, 
increased serologic responses to the DBL-CIDR domains 
compared to their corresponding DBL-α tags were 
observed for both children and adults.
Seroprevalence
Comparing the seroprevalence of DBL-α tags and DBL-
CIDR head structures, serorecognition of DBL-α tags did 
not consistently predict parent DBL-CIDR head struc-
ture serorecognition (Fig. 2). For two of the nine PfEMP1 
antigens, a discordant proportion of paediatric sera rec-
ognized the DBL-α tags compared to the proportion 
recognizing the corresponding parent DBL-CIDR head 
structure (PF3D7_0632500: P < 0.0001, PF3D7_01240600: 
P = 0.04, McNemar’s test; Fig.  2). For all nine PfEMP1 
antigens, a greater proportion of adult sera recognized 
the parent DBL-CIDR head structure compared to the 
proportion recognizing the corresponding DBL-α tag; 
however, the proportion was significantly discordant for 
three PfEMP1 antigens (PF3D7_1100200: P = 0.0009, 
PF3D7_0632500: P = 0.0008, PF3D7_0808700: P = 0.003, 
McNemar’s test; Fig. 2).
For three PfEMP1 antigens, paediatric and adult 
sera demonstrated equivalent DBL-α tag serorecogni-
tion, but the proportion of DBL-CIDR head structure 
serorecognition was greater in adults versus children 
(PF3D7_1100200: P < 0.05, PF3D7_0100300: P < 0.05, 
PF3D7_0200100: P < 0.05, PF3D7_0808700: P < 0.0001; 
PF3D7_0712000: P < 0.0001; Chi square test; Fig. 2). For 
PF3D7_0632500, sera from a minority of children and 
adults recognized the DBL-α tag, but sera from most 
children and adults recognized the parent DBL-CIDR 
domain head structure. This proportion was higher in 
adults compared to children for both the DBL-α tag 
(P < 0.0001; Chi square test) and the DBL-CIDR domain 
head structure (P < 0.001; Chi square test).
Children
As a group, Malian paediatric sera recognized two of 
nine DBL-α tags, three of nine DBL-CIDR head struc-
tures, and four of 18 downstream PfEMP1 fragments 
(Fig. 3). Of the three recognized parent DBL-CIDR head 
structures, children recognized only one corresponding 
DBL-α tag (from PF3D7_0617400). Paediatric sera recog-
nized the DBL-α tag from PfEMP1 PF3D7_0712000, but 
neither of the larger domain fragments that represented 
the extracellular region. Paediatric sera recognized all 
three ATS fragments, but only one of 18 extracellular 
PfEMP1 fragments downstream of the DBL-CIDR head 
structure.
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Fig. 1 Heat map of seroreactivity to 9 PfEMP1 DBL‑α tags and their parent DBL‑CIDR head structures for sera from 35 Malian children, 18 adults, and 
11 malaria‑naïve controls, with each protein fragment separated by row, including pre‑season seroreactivity and peak‑ or post‑season seroreactivity. 
Each column displays the profile of one serum sample. Seroreactivities of PfEMP1 protein fragments were ordered from least to most reactive 
parent DBL‑CIDR head structures. Individual serum samples within each subgroup were ordered from least to most seroreactive for all PfEMP1 
protein fragments. Grey indicates no seroreactivity, black is low to moderate seroreactivity, and red denotes high seroreactivity to probed fragments, 
measured by fluorescence intensity. Seroreactivity of malaria‑naïve controls was used to determine serorecognition of protein fragments by 
malaria exposed children and adults. PfEMP1, Plasmodium falciparum erythrocyte membrane protein‑1; DBL, Duffy binding‑like; CIDR, cysteine‑rich 
interdomain region
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Adults
Malian adult sera recognized all nine of the parent DBL-
CIDR head structures, but only four corresponding 
DBL-α tags (Fig. 3). Adult sera recognized all 11 down-
stream fragments and the two ATS fragments of the four 
PfEMP1 antigens with serorecognized DBL-α tags. In 
total, Malian adult sera recognized 4/9 DBL-α tags, 9/9 
parent DBL-CIDR head structures, and 18/18 down-
stream PfEMP1 fragments (Fig. 3).
Seroreactivity
Children
During a malaria transmission season, paediat-
ric sera had increased seroreactivity to two DBL-α 
tags (PF3D7_1300300: P = 0.04 and PF3D7_0712000: 
P = 0.02), but only one of the corresponding parent DBL-
CIDR head structures also had increased seroreactivity 
(PF3D7_0712000: P = 0.01; Fig. 3). Paediatric sera also had 
increased seroreactivity to two DBL-CIDR head structures 
(PF3D7_0632500: P = 0.01 and PF3D7_1240600: P = 0.01), 
but not to their corresponding DBL-α tags. Sera from chil-
dren had increased seroreactivity during a malaria trans-
mission season to only one downstream PfEMP1 fragment 
(PF3D7_1100200, P = 0.048; Wilcoxon signed-rank test).
Adults
For adults, seroreactivity to PfEMP1 antigens remained 
unchanged for all but one PfEMP1 fragment, which 
increased (the ATS of PF3D7_1300300: P = 0.02; 
Wilcoxon signed-rank test; Fig. 3) over the course of the 
malaria season.
Correlation of seroreactivity
For serum samples with serorecognition of a DBL-α tag 
and/or corresponding parent DBL-CIDR head structure, 
correlation of the reactivities to the DBL-α tag (measured 
by fluorescence intensity) and to the corresponding DBL-
CIDR domain was determined. Reactivity to a DBL-α tag 
did not correlate well with reactivity to the correspond-
ing parent DBL-CIDR head structure (Table  1). DBL-α 
tag seroreactivity significantly correlated with the par-
ent DBL-CIDR head structure seroreactivity for only two 
PfEMP1 antigens (PF3D7_1100200: rs= 0.81, P = 0.007; 
PF3D7_0712000: rs= 0.52, P = 0.002; Table 1).
Discussion
Serologic responses to a PfEMP1’s DBL-α tag region did 
not correlate with seasonal malaria exposure or with 
responses to the parent DBL-CIDR head structure in 
either adults or children from an area of Mali with intense 
seasonal exposure to P. falciparum malaria. Parent DBL-
CIDR head structures were better indicators of malaria 
exposure. Serologic prediction of malaria exposure may 
be better estimated by using larger PfEMP1 fragments, 
such as head structures that include conserved regions, 
as targets for serological testing.
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Fig. 2 Seroprevalence of DBL‑α tag fragments and parent DBL‑CIDR head structures recognized at pre‑season for each PfEMP1 in children and 
adults. Paediatric sera recognized a discordant proportion of the DBL‑α tag and parent DBL‑CIDR head structure for two PfEMP1s, PF3D7_0632500 
and PF3D7_0317400. Adult sera recognized discordant proportions of DBL‑α tag and parent DBL‑CIDR head structure for three PfEMP1s, 
PF3D7_1100200, PF3D7_0632500, and PF3D7_0808700. (*P < 0.05, **P < 0.01; ***P < 0.001. The McNemar’s test was used to compare tags and head 
structures within paediatric and adults groups. For comparisons between adults and children, the Chi square test was used.) PfEMP1, Plasmodium 
falciparum erythrocyte membrane protein‑1; DBL, Duffy binding‑like; CIDR, cysteine‑rich interdomain region
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DBL-α tags have been used as a unique “fingerprint” 
reflecting PfEMP1 diversity in gene expression, sero-
logic, and population genomics studies [4, 13–15]. These 
DBL-α tag sequences serve as a useful means of PfEMP1 
classification, because each PfEMP1 contains only one 
DBL-α domain and most PfEMP1 antigens include a 
DBL-α domain. The DBL-α tag consists of a 300 to 400 
base pair variable region flanked by conserved motifs that 
provide targets for degenerate primers [16, 17]. The find-
ings here suggest that such a unique sequence tag may 
not perform well as a sensitive marker for malaria expo-
sure, potentially due to the diverse nature of the protein 
fragment. Seroreactivity to the parent DBL-CIDR head 
structure containing more conserved sequences better 
identified age and seasonal malaria exposure.
Fig. 3 Serorecognition and seroreactivity patterns of Malian children (top) and adults (bottom) for 36 protein fragments of nine 3D7 PfEMP1 
antigens. Each DBL‑α tag of a PfEMP1 antigen is the first fragment shown. Group serorecognized fragments are indicated in red, while blue 
stripes indicate increased seroreactivity of a fragment over a malaria season from pre‑season to peak season for children and from pre‑season to 
post‑season for adults. PfEMP1, Plasmodium falciparum erythrocyte membrane protein‑1; DBL, Duffy binding‑like; CIDR, cysteine‑rich interdomain 
region; ATS, acidic terminal segment
Table 1 Correlation of  DBL-α tags and  parent DBL-CIDR 
head structures for serorecognized PfEMP1 fragments
PfEMP1 Plasmodium falciparum membrane protein-1, DBL Duffy binding-like, 
CIDR cysteine-rich interdomain region, rs Spearman correlation coefficient
var group PfEMP1 No. of serum samples 
with serorecognition 
of the fragment
rs P value
A PF3D7_1100200 11 0.81 0.007
PF3D7_1300300 13 0.42 0.15
A/var3 PF3D7_0100300 13 0.36 0.23
B PF3D7_0200100 17 0.33 0.19
B/A PF3D7_0632500 5 − 0.30 0.68
B/C PF3D7_0808700 9 0.58 0.11
C PF3D7_0712000 33 0.52 0.002
PF3D7_1240600 19 − 0.10 0.68
PF3D7_0617400 27 0.34 0.09
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These findings contrast with results from a study done 
in Papua New Guinea that found that serologic responses 
to DBL-α tags revealed differences in malaria exposure. 
One hundred twenty-three DBL-α tag sequences from 
Papua New Guinea populated a protein microarray that 
was used to seroprofile Papua New Guinea adults and 
children, revealing that children’s antibody responses 
peaked between four and 15  years of age [4]. In this 
Papua New Guinea population, DBL-α tags served as 
a marker for age-related exposure to malaria. Of note, 
DBL-α tags from Papua New Guinea are less diverse 
than DBL-α tags from global populations. In a popula-
tion genomic analysis of DBL-α tags from both Papua 
New Guinea and other malaria-endemic regions, the 
number of unique DBL-α tags plateaued with 30 Papua 
New Guinea isolates examined, but no such plateau was 
evident with more than 1000 DBL-α tag sequences from 
59 global isolates [2]. Serologic responses to Papua New 
Guinea DBL-α tags may therefore be more informative 
than responses to DBL-α tags in locations with more 
genetically diverse DBL-α tags. In the current study, age-
related Malian serologic responses to DBL-α tags were 
not observed. However, we evaluated fragments from 
nine PfEMP1 antigens compared to the 123 evaluated 
from Papua New Guinea. It is possible that with a large 
enough pool of DBL-α tags on a microarray and a larger 
sample size, differences in age-related exposure may be 
discerned.
Antibody responses to particular PfEMP1 domains 
have been associated with protection from clinical 
malaria in several studies [7, 18–20], and may play a role 
in protection from severe malaria disease. A recent study 
of antibody responses in Malian children with severe 
malarial anaemia and/or cerebral malaria found gaps in 
immunity to particular PfEMP1 antigens compared to 
uncomplicated malaria controls [5]. Sera from children 
with severe malaria recognized fewer PfEMP1 antigens 
and reacted less intensely to particular PfEMP1 frag-
ments compared to controls with uncomplicated malaria. 
Immunologic gaps included several DBL-CIDR domains, 
but only two associated DBL-α tags. In fact, immunologic 
gaps to particular DBL-CIDR head structures did not 
predict a gap to a particular DBL-α tag, and vice versa. 
This is consistent with the findings here that serologic 
responses to DBL-α tags were not as predictive as mark-
ers of malaria exposure compared to responses to larger 
PfEMP1 fragments such as head structures.
Earlier microarray studies have found that more con-
served PfEMP1 fragments are markers of malaria expo-
sure. In a study of Malian children and adults followed 
during the malaria season, the most differentially sero-
reactive fragments in adults compared to children con-
tained the intracellular ATS domain, which is more 
conserved than extracellular domains [11, 21]. Similarly, 
in this study, paediatric sera recognized all three of the 
ATS domains. In Malian P. falciparum genomes, DBL-α 
and DBL-β domains have more sequence conservation 
than other DBL domains [22]. Here, children recognized 
head structures containing DBL-α and DBL-β domains 
while other extracellular PfEMP1 domains with lower 
sequence conservation remained unrecognized. Taken 
together, these findings suggest that when using PfEMP1 
antigens as microarray markers of malaria exposure, the 
most conserved portions may be the most informative 
for malaria exposure. Such ordered serorecognition of 
PfEMP1 domains based on sequence conservation may 
also underlie the order of PfEMP1 domain recognition 
identified in Tanzanian children during the first 2  years 
of life [23, 24].
This study had some limitations. The examined DBL-α 
domains were from the reference strain 3D7, not from 
circulating Malian parasites in the population. In spite 
of this, individuals had seroreactivity to head structures 
and to the downstream PfEMP1 fragments, particularly 
Malian adults, who as a group recognized all DBL-CIDR 
head structures and downstream fragments. This sug-
gests that the PfEMP1 antigens from 3D7 may represent 
the much larger circulating PfEMP1 population in Mali to 
some degree. Another limitation is the limited DBL-α tag 
population studied: DBL-α tags from nine 3D7 PfEMP1 
antigens were examined, which represents only a small 
subset of the 60 3D7 PfEMP1 antigens, although at least 
one member of each PfEMP1 subgroup was included. 
This limited representation of PfEMP1 antigens could be 
another possible explanation for the limited serorecog-
nition by children. It is possible that DBL-α tags from 
other 3D7 PfEMP1 antigens could have elicited more 
serorecognition in Malian children, but were not repre-
sented on the microarray. Whereas proteins expressed on 
this microarray platform have been shown to induce anti-
body responses similar to those from purified proteins, 
these proteins are produced with an Escherichia coli 
system and lack post-translational modifications such as 
glycosylation [7]. Correct folding of the PfEMP1 proteins 
produced by the Escherichia coli expression system has 
not been confirmed.
To further examine the role of conserved PfEMP1 
domains in inducing serologic responses, peptide micro-
arrays are a potentially useful tool to identify reactive 
epitopes. Such an approach may provide insight dis-
tinct from protein microarrays, where entire domains 
are included and may elicit differential seroreactivity. A 
protein microarray does not permit identification of the 
specific roles of either more conserved or more diverse 
regions within a protein fragment. Peptide arrays have 
already been used as a tool for studying epitopes in 
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variant surface antigen proteins in Plasmodium falcipa-
rum. In particular, they have recently been used to pin-
point epitopes targeted by antibodies in a DBL-α domain 
that mediates rosetting [25] and epitopes within particu-
lar domains of STEVOR and RIFIN antigens reflecting 
malaria exposure [26]. This approach could be used to 
identify epitopes targeted by protective PfEMP1 antibod-
ies and thereby inform vaccine or therapeutics design.
Conclusions
Malian serologic responses to a PfEMP1’s DBL-α tag, a 
semi-conserved short fragment of the DBL-α domain, did 
not correlate with seasonal malaria exposure or responses 
to the parent DBL-CIDR head structure in either adults 
or children. Larger, more conserved PfEMP1 domains 
may be better indicators of malaria exposure than short, 
variable PfEMP1 fragments such as DBL-α tags. PfEMP1 
head structures that include conserved sequences are 
thus well suited for study as serologic predictors of 
malaria exposure on protein microarrays. Further sup-
port for this finding would include testing a broader 
panel of PfEMP1 antigens, including those from non-3D7 
reference strains and from endemic parasite genomes.
Additional file
Additional file 1. Sequences, classifications, and domains of the PfEMP1 
antigens used to populate the custom protein microarray.
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